Jain Viral G, Parikh Nehal A, Rysavy Matthew A, Shukla Vivek V, Saha Shampa, Hintz Susan, Jobe Alan, Carlo Waldemar A, Ambalavanan Namasivayam
University of Alabama at Birmingham, Birmingham, AL.
Perinatal Institute, Neurodevelopmental Disorders Prevention Center, Cincinnati Children's Hospital and University of Cincinnati College of Medicine, Cincinnati, OH.
Am J Obstet Gynecol. 2025 Feb 27. doi: 10.1016/j.ajog.2025.02.038.
The relationship between histological chorioamnionitis (inflammation of fetal membranes) and funisitis (inflammation of umbilical cord), both commonly associated with preterm birth, with subsequent development of cerebral palsy remains controversial.
To determine if extremely preterm infants (<27 weeks) exposed to histological chorioamnionitis or funisitis are at a higher risk of death or cerebral palsy compared to those without these exposures.
Multicenter cohort study of prospectively collected data of preterm infants in the National Institute of Child Health and Development Neonatal Research Network. Infants born 2012 to 2019 who were 22 to 26 weeks of gestation, received active treatment, and had placental pathology available were included. Because preterm birth, as measured by gestational age, lies on the causal pathway for cerebral palsy, we used mediation analysis to evaluate whether the indirect mediated effect of gestational age on death or cerebral palsy contributed to the relationships of histological chorioamnionitis and funisitis with death or cerebral palsy.
The primary outcome was the composite outcome of death or cerebral palsy defined by the Amiel-Tison standardized exam and Gross Motor Function Classification System ≥1 at 22 to 26 months corrected age.
A total of 6949 infants met the eligibility criteria. Of these, 3971 (57%) infants had histological chorioamnionitis, and 2978 (43%) did not have histological chorioamnionitis. About 90% (6248/6949) of infants had follow-up and complete cerebral palsy data. Similarly, 1057 (28%) infants had funisitis, and 2689 (72%) did not have funisitis. Of these, primary outcome data were available for 87% (3267/3746) infants. On multivariable analysis, histological chorioamnionitis was not associated with death or cerebral palsy (relative risk: 0.98 [95% confidence interval: 0.91, 1.05]). Exposure to funisitis was associated with a higher risk of death or cerebral palsy (relative risk: 1.09 [1.01, 1.21]) that was primarily mediated by preterm birth. There was a higher risk of cerebral palsy among surviving infants exposed to funisitis (relative risk: 1.23 [1.04, 1.51]) compared to those without funisitis. This association was partially (40%) mediated by preterm birth (relative risk: 1.08 [1.05, 1.12]), but the major effect (60%) appears to be a direct adverse effect of funisitis exposure on cerebral palsy development (relative risk: 1.13 [0.97, 1.40]).
Funisitis was associated with an increased risk of the combined outcome of death or cerebral palsy. In surviving infants, the direct adverse effects of funisitis appear to lead to cerebral palsy, independent of preterm birth.
组织学绒毛膜羊膜炎(胎膜炎症)与脐带炎(脐带炎症)之间的关系一直存在争议,这两种炎症都与早产及随后的脑瘫发展密切相关。
确定与未暴露于组织学绒毛膜羊膜炎或脐带炎的极早早产儿(<27周)相比,暴露于这些炎症的极早早产儿死亡或患脑瘫的风险是否更高。
对美国国立儿童健康与人类发展研究所新生儿研究网络中前瞻性收集的早产儿数据进行多中心队列研究。纳入2012年至2019年出生、孕周为22至26周、接受积极治疗且有胎盘病理检查结果的婴儿。由于按孕周衡量的早产处于脑瘫的因果路径上,我们使用中介分析来评估孕周对死亡或脑瘫的间接中介效应是否导致了组织学绒毛膜羊膜炎和脐带炎与死亡或脑瘫之间的关系。
主要结局是在矫正年龄22至26个月时,由阿米尔 - 蒂松标准化检查和粗大运动功能分类系统≥1定义的死亡或脑瘫复合结局。
共有6949名婴儿符合纳入标准。其中,3971名(57%)婴儿患有组织学绒毛膜羊膜炎,2978名(43%)婴儿未患组织学绒毛膜羊膜炎。约90%(6248/6949)的婴儿有随访和完整的脑瘫数据。同样,1057名(28%)婴儿患有脐带炎,2689名(72%)婴儿未患脐带炎。其中,87%(3267/3746)的婴儿有主要结局数据。在多变量分析中,组织学绒毛膜羊膜炎与死亡或脑瘫无关(相对风险:0.98[95%置信区间:0.91,1.05])。暴露于脐带炎与死亡或脑瘫的较高风险相关(相对风险:1.09[1.01,1.21]),这主要由早产介导。与未患脐带炎的存活婴儿相比,患脐带炎的存活婴儿患脑瘫的风险更高(相对风险:1.23[1.04,1.51])。这种关联部分(40%)由早产介导(相对风险:1.08[1.05,1.12]),但主要影响(60%)似乎是脐带炎暴露对脑瘫发展的直接不良影响(相对风险:1.13[0.97,1.40])。
脐带炎与死亡或脑瘫复合结局的风险增加有关。在存活婴儿中,脐带炎的直接不良影响似乎导致脑瘫,独立于早产。